Compare Asiaplast Industries Tbk (APLI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Asiaplast Industries Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asiaplast Industries Tbk trades at Rp256 (market cap 351.57B, 52.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Asiaplast Industries Tbk is far larger — about 2.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (187.4K versus 52.9K). Which is the better fit depends on your goals.
| APLI | OBAT | |
|---|---|---|
Market Cap | 351.57B | 164.65B |
Volume | 52.9K | 187.4K |
Lot | 529 | 1.87K |
Turnover | 13.49M | 44.35M |
Average Price | 255.09 | 236.67 |
Value | 13.49M | 44.35M |
Indicative Equilibrium Price | 256 | 242 |
Indicative Equilibrium Volume | 1 | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Asiaplast Industries Tbk
PT. Asiaplast Industries Tbk, formerly PT. Akasa Pandukarya and originally known as PT. Adi Karya Perkasa. The company started its commercial operations in 1994. Since November 1999, the company started to produce PVC synthetic leather. As of December 31, 2000, the Company has five production lines comprising of production lines I, II and III, which are used for producing PVC plastic sheets, with production capacity of 15,000 tons per year (un audited) and production lines IV, V, which are used for producing synthetic leather, with production capacity of 6, 500 tons per year (un audited). The Capital Investment Coordinating Board has approved the change of the Companys status from foreign capital investment to become domestic capital investment based on the letter No. 24/1/IP/I/PMDN/2015 dated February 18, 2015.
Read more on APLI →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
